Degree Name

Nursing Practice, DNP

Publication Date

2024

Upload Date

2024

First Advisor

Linda Latting

Abstract

Type 2 Diabetes Mellitus (T2DM) has the potential for multiple complications which include non-alcoholic fatty liver disease (NAFLD). The American Diabetes Association (ADA) updated its guidelines recommending screening of patients with T2DM for NAFLD (ADA, 2023). Screening is prompted by the increased incidence of NAFLD in patients with T2DM. Approximately 70% of people with T2DM suffer from NAFLD which can progress to hepatic steatosis or non-alcoholic steatohepatitis (NASH) (ADA, 2023). NALFD is a common diagnosis leading to the need for liver transplantation (Alkhouri et al., 2020). This project aims to determine if an education program for primary care providers and staff can improve their learning self-efficacy (L-SES) in screening and managing NAFLD in patients with T2DM. Participants included physicians, nurse practitioners, registered nurses, licensed practical nurses, and pharmacists. They serve as primary care providers at a federally funded hospital system in Central Arkansas. Participants attended a 20-minute session that emphasized the importance of screening and management of NAFLD in patients with T2DM. A pre and post-test was project implementation. A paired t-test was used for analysis with an alpha level of 0.05. This analysis showed a statistically significant increase in post-test scores with a p-value of 0.002. This data showed an evidence-based education program can improve providers' learning self-efficacy in screening and management of NALFD in patients with T2DM which can lead to policy change and improvement in clinical practice.

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Download

Share

COinS